Avanos Medical, Inc. (AVNS) Tops Q2 EPS by 3c; Offers FY22 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Avanos Medical, Inc. Announces Second Quarter 2022 Results
August 9, 2022 7:00 AM EDTALPHARETTA, Ga., Aug. 9, 2022 /PRNewswire/ --Â Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2022 financial results.
"Despite ongoing raw material availability and associated supply chain disruptions, underlying demand for our products remains... More
